Compositions and methods to affect skin irritation
Compositions are described that contain treated chitosan, modified chitosan and/or modified and treated chitosan for use in formulations for skin, hair and nails, and in compositions and methods of reducing topical agent-induced skin irritation and inflammation.
1. A method for reducing skin inflammation and/or skin irritation and/or topical irritant-induced IL-1α secretion, comprising topically applying a composition comprising:
(a) at least one topical irritating agent comprising sodium dodecyl sulfate (SDS) or a sunscreen agent that causes skin inflammation and/or skin inflammation and/or an increase in IL-1α secretion, or a combination thereof, wherein the SDS or the sunscreen agent is present in an amount of 0.04-5% W/V of the total weight of the composition; and
(b) at least one chitosan covalently modified with octane sulfonic acid via sulfonamide linkage (OsC), wherein the OsC is present in an amount of about 0.5-5% W/V of the total weight of the composition, wherein duration of contact between skin and the composition results in skin irritation, skin inflammation and/or IL-1α secretion, and wherein the composition provides a reduction in the skin irritation and/or a reduction in the skin inflammation and/or a reduction in the IL-1α secretion after contact with the composition compared with a control composition comprising the topical irritating agent but not the chitosan.
2. The method of claim 1 , which is in the form of a solution, suspension, emulsion, lotion, cream, gel, stick, spray, ointment, hair conditioner, paste, foam, powder, mousse, solid bar, shaving cream, shaving gel, wipe, patch, hydrogel, or mask.
3. The method of claim 1 , wherein the OsC comprises about 1-5% W/V of the total weight of the composition.
4. The method of claim 1 , wherein the OsC comprises about 0.5-3% W/V of the total weight of the composition.
5. The method of claim 1 , wherein the OsC comprises about 0.5-2% W/V of the total weight of the composition.
6. The method of claim 1 , wherein the topical irritating agent comprises SDS.
7. The method of claim 1 , wherein the topical irritating agent comprises the sunscreen agent.
8. The composition of claim 1 , wherein the OsC comprises about 1-3% W/V of the total weight of the composition.
9. The composition of claim 1 , wherein the OsC comprises about 1-2% W/V of the total weight of the composition.
10. The composition of claim 1 , wherein the SDS comprises about 0.2-5% W/V of the total weight of the composition.
11. The composition of claim 1 , wherein the SDS comprises about 0.4-5% W/V of the total weight of the composition.
12. The composition of claim 1 , wherein the SDS comprises about 0.6-5% W/V of the total weight of the composition.